Biotricity regains Nasdaq minimum bid price compliance

BIOTRICITY INC.

Received Nasdaq notice on July 18, 2023 confirming compliance with Rule 5550(a)(2).
Previous deficiency notification was received on January 20, 2023 for bid price below $1.00.
Nasdaq has closed the matter; no further action required.

item 8.01

BIOTRICITY INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-025121

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.